Overview
David Smil practices practicing medicine in Toronto, Canada.
His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant and Glioma.
He is actively involved in clinical research, co-authoring 37 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about David Smil
Is David Smil a top-rated expert for Diffuse Midline Glioma H3 K27M-Mutant?
MediFind is an objective health platform that identifies experts based on real-world data. David Smil is classified as an Experienced expert for Diffuse Midline Glioma H3 K27M-Mutant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does David Smil participate in research or clinical trials?
Yes. David Smil has published 37 articles and abstracts on conditions like Diffuse Midline Glioma H3 K27M-Mutant. You can view a list of David Smil's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers